ArticleHuman vaccines & immunotherapeutics2020
Mortality burden from seasonal influenza in Chongqing, China, 2012-2018.
Article in Human vaccines & immunotherapeutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 28 citations in OpenAlex.
- Disease burden of seasonal influenza in China from 2010 to 2019: A systematic review and meta-analysis based on multiple indicators.Human vaccines & immunotherapeutics · 2025Pooled it
- High Clinical Burden of Influenza Disease in Adults Aged ≥ 65 Years: Can We Do Better? A Systematic Literature Review.Advances in therapy · 2023Pooled it
- The economic burden of seasonal influenza - China, 2010-2019.Human vaccines & immunotherapeutics · 2026Article
- Three-stage interpretability analysis of influenza virus and meteorological correlation in Jiuquan City, 2016-2025: SARIMAX + TreeSHAP.Frontiers in cellular and infection microbiology · 2026Article
- A study on the climate-driven spatiotemporal dynamics of influenza in Lanzhou spanning the COVID-19 era.Frontiers in cellular and infection microbiology · 2026Article
- Epidemiology of human respiratory tract infection in Chongqing, China after COVID-19-based on surveillance data encompassing 17 respiratory pathogens.Frontiers in cellular and infection microbiology · 2025Article
- Epidemic patterns of the different influenza virus types and subtypes/lineages for 10 years in Chongqing, China, 2010-2019.Human vaccines & immunotherapeutics · 2024Article
- Effectiveness of influenza vaccine among the population in Chongqing, China, 2018-2022: A test negative design-based evaluation.Human vaccines & immunotherapeutics · 2024Observational
- Article
- Influenza-Associated Excess Mortality by Age, Sex, and Subtype/Lineage: Population-Based Time-Series Study With a Distributed-Lag Nonlinear Model.JMIR public health and surveillance · 2023Article
- Evaluation of influenza vaccination coverage in Shanghai city during the 2016/17 to 2020/21 influenza seasons.Human vaccines & immunotherapeutics · 2022Article
- Analysis of influenza trend and impact of COVID-19 in Kezhou, Xinjiang for 8 consecutive years.Journal of medical virology · 2022Article
- Epidemiological and Clinical Characteristics of Influenza Outbreaks Among Children in Chongqing, China.Frontiers in public health · 2022Article
- Knowledge, attitudes and practices related to influenza and influenza vaccine among healthcare workers in Chongqing, China-a cross-sectional study.Human vaccines & immunotherapeutics · 2021Article
- Comparison of influenza surveillance systems in Australia, China, Malaysia and expert recommendations for influenza control.BMC public health · 2021Article
- Effect of meteorological factors on the activity of influenza in Chongqing, China, 2012-2019.PloS one · 2021Article
- Immune Mechanisms in Cardiovascular Diseases Associated With Viral Infection.Frontiers in immunology · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo estimate influenza-associated excess mortality rates (EMRs) in Chongqing from 2012 to 2018.
methodsWe obtained weekly mortality data for all-cause and four underlying causes of death (circulatory and respiratory disease (CRD), pneumonia and influenza (P&I), chronic obstructive pulmonary disease (COPD) and ischemic heart disease (IDH)), and influenza surveillance data, from 2012 to 2018. A negative-binomial regression model was used to estimate influenza-associated EMRs in two age groups (<65 years and ≥65 years).
resultsIt was estimated that an annual average of 10025 influenza-associated deaths occurred in Chongqing, corresponding to 5.2% of all deaths. The average EMR for all-cause death associated with influenza was 33.5 (95% confidence interval (
conclusionsInfluenza was associated with substantial EMRs in Chongqing, especially among elderly people. Influenza B virus caused a relatively higher excess mortality impact compared with A(H1N1)pdm09 and A(H3N2). It is advisable to optimize future seasonal influenza vaccine reimbursement policy in Chongqing to curb disease burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.